🏁 Our program on cellular residual disease in triple negative breast cancer is about to launch!

Detecting circulating tumor cells in early #TNBC will provide deeper insights into the metastatic process and #immunotherapy response

#BreastCancer #LiquidBiopsy #CTC #PrecisionMedicine

Intriguing data presented by @lfoffano.bsky.social at the #SABCS24 poster session on how #ctDNA can be leveraged to enhance disease monitoring in metastatic #BreastCancer.

Paving the way to a new #liquidbiopsy informed RECIST

#PrecisionMedicine #bcsm

#EMBER3 takeaways:

imlunestrant 🔼 PFS in patients with #ESR1 mut #MBC (5.5 vs. 3.8 mo)

Combination with abemaciclib further 🔼 PFS regardless of ESR1 and PIK3CA #ctDNA status (9.4 vs. 5.5 mo)

Previous CDK4/6i were mainly Palbo and Ribo in the MBC setting

#SABCS24 #bcsm #BreastCancer

Awesome day here in Udine for the #TelethonUdine marathon!

This year is an #Oncology and #Genetics joint venture 🏃‍♀️🏃

#UniudRunsForResearch #CroAviano